XML 26 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivative Instruments
9 Months Ended
Sep. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments
Note 4 - Derivative Instruments
 
In February 2014, the Company began offering fixed indexed annuity products (“FIA”), which are deferred fixed annuities that guarantee the return of principal to the contractholder and credit interest based on a percentage of the gain in a specified market index. In October 2015, the Company began offering indexed universal life products (“IUL”), which also credit interest based on a percentage of the gain in a specified market index. When deposits are received for FIA and IUL contracts, a portion is used to purchase derivatives consisting of call options on the applicable market indices to fund the index credits due to FIA and IUL policyholders. For the Company, substantially all such call options are one-year options purchased to match the funding requirements of the underlying contracts. The call options are carried at fair value with the change in fair value included in Net Realized Investment Gains (Losses), a component of revenues, in the Consolidated Statements of Operations. The change in fair value of derivatives includes the gains or losses recognized at the expiration of the option term or early termination and the changes in fair value for open positions. Call options are not purchased to fund the index liabilities which may arise after the next deposit anniversary date. On the respective anniversary dates of the indexed deposits, the index used to compute the annual index credit is reset and new one-year call options are purchased to fund the next annual index credit. The cost of these purchases is managed through the terms of the FIA and IUL contracts, which permit changes to index return caps, participation rates and/or asset fees, subject to guaranteed minimums on each contract’s anniversary date. By adjusting the index return caps, participation rates or asset fees, crediting rates generally can be managed except in cases where the contractual features would prevent further modifications.
 
The future annual index credits on fixed indexed annuities are treated as a “series of embedded derivatives” over the expected life of the applicable contract with a corresponding reserve recorded. For the indexed universal life contracts, the embedded derivative represents a single year liability for the index return.
 
The Company carries all derivative instruments as assets or liabilities in the Consolidated Balance Sheets at fair value. The Company elected to not use hedge accounting for derivative transactions related to the FIA and IUL products. As a result, the Company records the purchased call options and the embedded derivatives related to the provision of a contingent return at fair value, with changes in the fair value of the derivatives recognized immediately in the Consolidated Statements of Operations. The fair values of derivative instruments, including derivative instruments embedded in FIA and IUL contracts, presented in the Consolidated Balance Sheets were as follows:
 
 
 
September 30,
 
December 31,
 
 
2016
 
2015
Assets
 
 
 
 
 
 
 
 
 
 
Derivative instruments, included in Short-term
 
 
 
 
 
 
 
 
 
 
and Other Investments
 
 
$
4,534
 
 
 
$
2,501
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
Fixed indexed annuities - embedded derivatives,
 
 
 
 
 
 
 
 
 
 
included in Other Policyholder Funds
 
 
 
55,179
 
 
 
 
39,021
 
Indexed universal life - embedded derivatives,
 
 
 
 
 
 
 
 
 
 
included in Investment Contract and Life Policy Reserves
 
 
 
80
 
 
 
 
14
 
 
In general, the change in the fair value of the embedded derivatives related to the fixed indexed annuities will not correspond to the change in fair value of the purchased call options because the purchased call options are one-year options while the options valued in those embedded derivatives represent the rights of the policyholder to receive index credits over the entire period the fixed indexed annuities are expected to be in force, which typically exceeds 10 years. The changes in fair value of derivatives included in the Consolidated Statements of Operations were as follows:
 
Three Months Ended
Nine Months Ended
September 30,
September 30,
2016
2015
2016
2015
Change in fair value of derivatives (1):
Revenues
Net realized investment gains (losses)
$
562
$
(1,564
)
$
422
$
(2,171
)
Change in fair value of embedded derivatives:
Revenues
Net realized investment gains (losses)
(76
)
1,328
(2,077
)
1,795
 
(1)
Includes the gains or losses recognized at the expiration of the option term or early termination and the changes in fair value for open options.
 
The Company’s strategy attempts to mitigate potential risk of loss under these agreements through a regular monitoring process, which evaluates the program’s effectiveness. The Company is exposed to risk of loss in the event of nonperformance by the counterparties and, accordingly, option contracts are purchased from multiple counterparties, which are evaluated for creditworthiness prior to purchase of the contracts. All of these options have been purchased from nationally recognized financial institutions with a Standard and Poor’s/Moody’s long-term credit rating of “BBB+”/“Baa1” or higher at the time of purchase and the maximum credit exposure to any single counterparty is subject to concentration limits. The Company also obtains credit support agreements that allow it to request the counterparty to provide collateral when the fair value of the exposure to the counterparty exceeds specified amounts.
 
The notional amount and fair value of call options by counterparty and each counterparty’s long-term credit ratings were as follows:
 
September 30, 2016
December 31, 2015
Credit Rating (1)
Notional
Fair
Notional
Fair
Counterparty
S&P
Moody’s
Amount
Value
Amount
Value
Bank of America, N.A.
A
A1
$
38,500
$
1,598
$
17,000
$
5
Barclays Bank PLC
A-
A2
41,400
720
7,600
137
Citigroup Inc.
BBB+
Baa1
5,800
2
17,300
845
Credit Suisse International
A
A2
64,300
1,442
12,000
167
Societe Generale
A
A2
23,200
772
80,800
1,347
Total
$
173,200
$
4,534
$
134,700
$
2,501
 
(1)
As assigned by Standard & Poor’s Corporation (“S&P”) and Moody’s Investors Service, Inc. (“Moody’s”).
 
As of September 30, 2016 and December 31, 2015, the Company held $4,770 and $2,617, respectively, of cash received from counterparties for derivative collateral, which is included in Other Liabilities on the Consolidated Balance Sheets. This derivative collateral limits the Company’s maximum amount of economic loss due to credit risk that would be incurred if parties to the call options failed completely to perform according to the terms of the contracts to $250 per counterparty.